AOSL vs REGN · rev $678.9M vs P/E 14, rev $4.29B
Alpha and Omega Semiconductor Ltd (AOSL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Alpha and Omega Semiconductor Ltd (AOSL) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
Latest reported AOSL revenue for 2026-06-30 was $678.9M. Net income was -$42.3M. Revenue was down 2.5% from 2025-06-30 to 2026-06-30. AOSL currently screens at market cap $832.4M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AOSL currently screens at market cap $832.4M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AOSL and REGN stock pages for the full models.
Not investment advice.